George E. Tiller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
George E. Tiller has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- John C. Mulley
Faculty of Medicine The George Institute for Global Heath UNSW Sydney Australia
2 shared publications - Jozef Gecz
Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, Australia
2 shared publications - A K Gedeon
Centre for Medical Genetics, Department of Cytogenetics and Molecular Genetics, Women's and Children's Hospital, and University of Adelaide Department of Paediatrics, Adelaide, Australia
1 shared publication Adam Kundishora
Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut
1 shared publicationAlison Colley
Department of Clinical Genetics, Liverpool Health Service, Liverpool, NSW 2170, Australia
1 shared publication- Andrea Klunder Petersen
Department of Genetics and Metabolism, Randall Children's Hospital at Legacy Emanuel Medical Center, Portland, Oregon, USA
1 shared publication
Latest Publications
- 24 August 2023
- Published by Elsevier in Pediatric Neurology
- Vol. 148, 164-171
De Novo Variants in RAB11B Cause Various Degrees of Global Developmental Delay and Intellectual Disability in Children
- 24 August 2023
- Published by Elsevier in Pediatric Neurology
- Vol. 148, 164-171
De Novo Variants in RAB11B Cause Various Degrees of Global Developmental Delay and Intellectual Disability in Children
- 1 June 2001
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 68 (6) , 1386-1397
The Molecular Basis of X-Linked Spondyloepiphyseal Dysplasia Tarda
- 1 June 2001
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 68 (6) , 1386-1397
The Molecular Basis of X-Linked Spondyloepiphyseal Dysplasia Tarda
- 1 August 1999
- Published by Springer Nature in Nature Genetics
- Vol. 22 (4) , 400-404
Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda
Spondyloepiphyseal dysplasia tarda (SEDL; MIM 313400) is an X-linked recessive osteochondrodysplasia that occurs in approximately two of every one million people1. This progressive skeletal disorder which manifests in childhood is characterized by disproportionate short stature with short neck and trunk, barrel chest and absence of systemic complications2,3,4. Distinctive radiological signs are platyspondyly with hump-shaped central and posterior portions, narrow disc spaces, and mild to moderate epiphyseal dysplasia. The latter usually leads to premature secondary osteoarthritis often requiring hip arthroplasty3,4,5. Obligate female carriers are generally clinically and radiographically indistinguishable from the general population4,5, although some cases have phenotypic changes consistent with expression of the gene defect2,4,6,7. The SEDL gene has been localized to Xp22 (Refs 8,9) in the approximately 2-Mb interval between DXS16 and DXS987 (ref. 10). Here we confirm and refine this localization to an interval of less than 170 kb by critical recombination events at DXS16 and AFMa124wc1 in two families. In one candidate gene we detected three dinucleotide deletions in three Australian families which effect frameshifts causing premature stop codons. The gene designated SEDL is transcribed as a 2.8-kb transcript in many tissues including fetal cartilage. SEDL encodes a 140 amino acid protein with a putative role in endoplasmic reticulum (ER)-to-Golgi vesicular transport.
- 1 August 1999
- Published by Springer Nature in Nature Genetics
- Vol. 22 (4) , 400-404
Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda
Spondyloepiphyseal dysplasia tarda (SEDL; MIM 313400) is an X-linked recessive osteochondrodysplasia that occurs in approximately two of every one million people1. This progressive skeletal disorder which manifests in childhood is characterized by disproportionate short stature with short neck and trunk, barrel chest and absence of systemic complications2,3,4. Distinctive radiological signs are platyspondyly with hump-shaped central and posterior portions, narrow disc spaces, and mild to moderate epiphyseal dysplasia. The latter usually leads to premature secondary osteoarthritis often requiring hip arthroplasty3,4,5. Obligate female carriers are generally clinically and radiographically indistinguishable from the general population4,5, although some cases have phenotypic changes consistent with expression of the gene defect2,4,6,7. The SEDL gene has been localized to Xp22 (Refs 8,9) in the approximately 2-Mb interval between DXS16 and DXS987 (ref. 10). Here we confirm and refine this localization to an interval of less than 170 kb by critical recombination events at DXS16 and AFMa124wc1 in two families. In one candidate gene we detected three dinucleotide deletions in three Australian families which effect frameshifts causing premature stop codons. The gene designated SEDL is transcribed as a 2.8-kb transcript in many tissues including fetal cartilage. SEDL encodes a 140 amino acid protein with a putative role in endoplasmic reticulum (ER)-to-Golgi vesicular transport.